.... The carcinosarcoma was resistant to anti-androgen therapy, and the patient showed low level of serum prostatic acid phosphatase and was free from bony metastases despite multile metastases to the lung, liver, pancreas, para-aortic lymph nodes, spleen and penis. The sarcomatous component consisted of chondrosarcoma...

...Isoji Sasagawa; Teruhiro Nakada; Tohru Hashimoto; Manabu Ishigooka; Yoko Kubota; Kazuhiko Hirano; Junji Hirano; Yukihiro Suzuki Serum concentrations of prostatic acid phosphatase (PAP), Γ-seminoprotein (Γ -Sm) and prostatic specific antigen (PSA) were measured in 31 hemodialysis patients without...

... adenocarcinoma. Histological features of the two tumors differed and double cancer was suspected by conventional pathological study. However, immunohistochemical staining with prostatic specific antigen and prostatic acid phosphatase was positive in each tumor. These results indicate the breast tumor...

...Peter J. Moberg; Jorge Lizana; Peter Eneroth Prostatic acid phosphatase (PAP) – a specific marker of prostatic secretion – has been analyzed by radioimmunoassay in samples of urine voided before and after massage of the prostate. In all patients there was an increase in urine PAP concentration...

...Yoichi Arai; Tatsuhiro Yoshiki; Ken-Ichiro Okada; Osamu Yoshida Serum prostatic specific antigen (PA), Γ-seminoprotein (Γ-Sm) and prostatic acid phosphatase (PAP) were evaluated in 141 patients with prostatic cancer, 121 of whom were newly diagnosed. Of the 121 untreated patients, 77, 71 and 67...

...Susumu Kodama; Hiroshi Itoh; Hisamitsu Ide; Hiroaki Kataoka; Toshiyuki Takehara; Masashi Nagano; Ryoichi Hamasuna; Masashi Koono; Yukio Osada Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) are well known as specific tumor markers of prostate cancer, but carcinoembryonic...